Epidemiology and treatment of psoriasis: a Chinese perspective

Abstract

Background: Psoriasis is a chronic inflammatory skin disease that has a negative impact on quality of life. Prevalence and management of psoriasis varies among different ethnic groups. Objectives: To evaluate the epidemiology and treatment of psoriasis from a Chinese perspective. Methods: A systematic search was performed on PubMed and the China National Knowledge Infrastructure using the following MeSH terms: "psoriasis" and ("prevalence" or "epidemiology") and "risk factor" and ("management" or "treatment"). The search included all citations from 1975 to 2013. Data were sorted by prevalence, age of onset, sex distribution, type, severity, risk factors, and management and treatment. Severity of psoriasis was classified as mild, moderate, or severe. The studies cited in this review involved Chinese subjects. Results: The prevalence of psoriasis in the People's Republic of China ranged from 0.11% to 0.47%. Genetic and environmental factors played an important role in initiation and exacerbation of psoriasis. Results showed that psoriasis can occur at any age but is more common in young and middle-aged individuals and occurs more often in men and earlier in women. Psoriasis vulgaris accounted for 82.6%-97.1% of psoriasis patients. More than 90% of patients with psoriasis were classified as mild or moderately severe. Risk factors are numerous. Management and treatment was based on classification level. Conclusion:The prevalence of psoriasis in Chinese patients is lower than that in Caucasians. A cold and dry climate, bacterial infection, diet, and stress are important risk factors for developing psoriasis. There are a variety of management and treatment options available. As such, Chinese patients with psoriasis can receive effective, safe, and individualized treatment.

Burden of psoriasis in young adults worldwide from the global burden of disease study 2019

“…In contrast, Tropical Latin America, Western Europe, and High-income Asia Pacific had the slowest decreases, which could be partly attributed to the increasing prevalence of obesity, a known risk factor for psoriasis ( 18 ). France, Finland, and Iceland had the highest national burdens of psoriasis in young people in 2019, possibly due to genetic, environmental, and lifestyle factors, as psoriasis has been found to be more common in cold, dry climates ( 19 ). Japan, Sweden, and Somalia experienced the largest average annual percent changes in the age-standardized incidence rate of psoriasis among young people from 1990 to 2019, This could be related to economic development, advancements in medical technology, and improvements in prevention methods and treatments for psoriasis in these countries during the specified period ( 20 ).…”

Impact of COVID-19 on medical care conduct and psychological burden among patients with psoriasis: real-world data from a tertiary hospital in China

“…Psoriasis is a common chronic recurrent inflammatory skin disease with a prevalence ranging from 0.11% to 0.47% in China. 1 Patients with psoriasis need long-term treatment. Regardless of whether they are treated with drugs or phototherapy, patients with psoriasis must visit the hospital regularly, and such visits may increase the risk of COVID-19 nosocomial infection.…”

Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective

“…In China, it affects 7.6 million individuals, resulting into age-standardized prevalence rate of 0.4% [ 2 , 3 ]. Plaque psoriasis is the most common type of psoriasis, accounting for over 96.0% of all cases [ 4 , 5 ]. On the basis of the body surface area (BSA) involvement, around 57.3% of patients have moderate-to-severe disease [ 4 ].…”